Deflazacort modulates the fibrinolytic pattern and reduces uPA-dependent chemioinvasion and proliferation in rheumatoid arthritis synoviocytes

Rheumatology

Volumn 44, Issue 10, 2005, Pages 1255-1262

  Del Rosso, A ^a   Cinelli, M ^a   Guiducci, S ^a   Pignone, A ^a   Fibbi, G ^a   Margheri, F ^a   Gabrielli, A ^b   Giacomelli, R ^c   Coppini, A ^d   Del Rosso, M ^a   Cerinic, M Matucci ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

^d Laboratori Guidotti SpA   (Italy)

Author keywords

Deflazacort; Fibrinolysis; Rheumatoid Arthritis; Steroids; Synoviocytes; uPA

Indexed keywords

DEFLAZACORT; MATRIGEL; MESSENGER RNA; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN ANTIBODY; UROKINASE; UROKINASE RECEPTOR;

ARTICLE; CELL COUNT; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; ZYMOGRAPHY;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CELL PROLIFERATION; CELLS, CULTURED; CHEMOTAXIS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FIBRINOLYSIS; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; PREGNENEDIONES; RECEPTORS, CELL SURFACE; RNA, MESSENGER; SYNOVIAL MEMBRANE; URINARY PLASMINOGEN ACTIVATOR;

EID: 27144515911     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kei006     Document Type: Article

References (31)

1. Firestein GS. Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors? Arthritis Rheum 1996;39:1781-90.
2. Mignatti P, Rifkin DB. Biology and biochemistry of proteinase in tumor invasion. Physiol Rev 1993;73:161-95.
3. Bouck N, Stellmach V, Hsu SC. How tumors become angiogenetic. Adv Cancer Res 1996;69:135-74.
4. Hollander AP, Dieppe PA, Atkins RM, Elson CJ. Cartilage catabolic cofactors in human arthritis. J Rheumatol 1993;20:223-4.
5. Plow EF, Freaney DE, Plescia J, Miles LA. The plasminogen system and cell surfaces: Evidence for plasminogen and urokinase receptors on the same cell type. J Cell Biol 1986;103:2411-20.
6. Mignatti P, Rifkin DB. Nonenzymatic interactions between proteinases and the cell surface: Novel roles in normal and malignant cell physiology. Adv Cancer Res 2000;78:103-57.
7. Busso N, Peclat V, So A, Sappino AP. Plasminogen activation in synovial tissues: Differences between normal, osteoarthritis, and rheumatoid arthritis joints. Ann Rheum Dis 1997;56:550-7.
8. Ronday HK, Smits HH, Quax PH et al. Bone matrix degradation by the plasminogen activation system. Possible mechanism of bone destruction in arthritis. Br J Rheumatol 1997;36:9-15.
9. Matucci Cerinic M, Generini S, Partsch G et al. Synoviocytes from osteoarthritis and rheumatoid arthritis produce plasminogen activators and plasminogen activator inhibitor-1 and display uPA receptor on their surface. Life Sci 1998;63:441-53.
10. Guiducci S, Del Rosso A. Cinelli M et al. Rheumatoid synovial fibroblasts constitutively express the fibrinolytic pattern of invasive tumor-like cells. Clin Exp Rheumatol 2005;23:364-72.
11. Ronday HK, Smits HH, Van Muijen GN et al. Difference in expression of plasminogen activation system in synovial tissue of patients with rheumatoid arthritis and osteoarthritis. Br J Rheumatol 1996;35:416-23.
12. Watanabe N, Ando K, Yoshida S et al. Gene expression profile analysis of rheumatoid synovial fibroblast cultures revealing the over-expression of genes responsible for tumor-like growth of rheumatoid synovium. Biochem Biophys Res Commun 2002;294:1121-9.
13. Fibbi G, Ziche M, Morbidelli L, Magnelli L, Del Rosso M. Interaction of urokinase with specific receptors stimulates mobilization of bovine adrenal capillary endothelial cells. Exp Cell Res 1988;179:385-95.
14. Kirchheimer JC, Wojta J, Christ G, Binder BR. Proliferation of a human epidermal cell line stimulated by urokinase. FASEB J 1987; 1:125-8.
15. Anichini E, Fibbi G, Pucci M, Caldini R, Chevanne M, Del Rosso M, Production of second messengers following chemotactic and mitogenic urokinase-receptor. Exp Cell Res 1994;213:438-48.
16. Fibbi G, Magnelli L, Pucci M, Del Rosso M. Interaction of urokinase with the receptor of human keratinocytes stimulates release of urokinase-like plasminogen activator. Exp Cell Res 1990;187:33-8.
17. Fibbi G, Pucci M, Serni U, Matucci Cerinic M, Del Rosso M. Antisense targeting of the urokinase receptor blocks urokinase-dependent Proliferation, chemoinvasion, and chemotaxis of human synovial cells and chondrocytes in vitro. Proc Assoc Am Phys 1998; 110:1-11.
18. Hickling P, Jacoby RK, Kirwan JR. Joint destruction after glucocorticoids are withdrawn in early rheumatoid arthritis. Arthritis and Rheumatism Council Low Dose Glucocorticoid Study Group. Br J Rheumatol 1998;37:930-6.
19. Kirwan JR. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group. N Engl J Med 1995;333:142-6.
20. Kirwan JR. The relationship between synovitis and erosions in rheumatoid arthritis. Br J Rheumatol 1997;36:225-8.
21. Markham A, Bryson HM. Deflazacort. A review of its pharmacological properties and therapeutic efficacy. Drugs 1995;50:317-33.
22. Straub RH, Gunzler C, Miller LE, Cutolo M, Scholmerich J, Schill S. Anti-inflammatory cooperativity of corticosteroids and norepinephrine in rheumatoid arthritis synovial tissue in vivo and in vitro. FASEB J 2002;16:993-1000.
23. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
24. Fibbi G, Barletta E, Dini G et al. Cell invasion is affected by differential expression of the urokinase plasminogen activator/urokinase plasminogen activator receptor system in muscle satellite cells from normal and dystrophic patients. Lab Invest 2001;81:27-39.
25. Bator JM, Cohen RL, Chambers DA. Hydrocortisone regulates the dynamics of plasminogen activators and plasminogen activator inhibitor expression in cultured murine keratinocytes. Exp Cell Res 1998;242:110-9.
26. Warburton MJ, Dundas SR, Gusterson BA, O'Hare MJ. Regulation of urokinase-type plasminogen activator production in rat mammary myoepithelial cells. Exp Cell Res 1996;228:76-83.
27. Del Rosso M, Fibbi G, Pucci M et al. Multiple pathways of cell invasion are regulated by multiple families of serine proteases. Clin Exp Metastasis 2002;19:193-207.
28. Hamilton JA, Piccoli DS, Cebon J et al. Cytokine regulation of colony-stimulating factor (CSF) production in cultured human synovial fibroblasts. II. Similarities and differences in the control of interleukin-1 induction of granulocyte-macrophage CSF and granulocyte CSF production. Blood 1992;79:1413-9.
29. Ritchlin C. Fibroblast biology: Effector signals released by the synovial fibroblast in arthritis. Arthritis Res 2000;2:356-60.
30. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
31. van der Heijde D. How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol 2000;27:261-3.